Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Photosensitizing Agents | 7 | 2018 | 20 | 3.900 |
Why?
|
| Photochemotherapy | 6 | 2018 | 16 | 2.900 |
Why?
|
| Neoplasms | 5 | 2018 | 611 | 1.800 |
Why?
|
| Drug Delivery Systems | 4 | 2018 | 91 | 1.710 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2018 | 100 | 1.460 |
Why?
|
| Oligonucleotides, Antisense | 5 | 2015 | 31 | 1.450 |
Why?
|
| Oligonucleotides | 4 | 2018 | 27 | 1.270 |
Why?
|
| Albumins | 2 | 2017 | 38 | 1.110 |
Why?
|
| Cell Line, Tumor | 10 | 2018 | 710 | 1.110 |
Why?
|
| Dendrimers | 2 | 2015 | 2 | 1.100 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 573 | 0.960 |
Why?
|
| Drug Carriers | 2 | 2015 | 16 | 0.950 |
Why?
|
| Endocytosis | 3 | 2015 | 12 | 0.940 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2018 | 14 | 0.690 |
Why?
|
| Immunoconjugates | 1 | 2018 | 11 | 0.680 |
Why?
|
| Antibodies | 1 | 2018 | 56 | 0.680 |
Why?
|
| Transfection | 3 | 2015 | 195 | 0.650 |
Why?
|
| Mice | 7 | 2018 | 2401 | 0.650 |
Why?
|
| Molecular Probes | 1 | 2017 | 15 | 0.640 |
Why?
|
| Mice, Nude | 4 | 2018 | 279 | 0.630 |
Why?
|
| Molecular Imaging | 1 | 2017 | 22 | 0.630 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 88 | 0.610 |
Why?
|
| Nanoparticles | 1 | 2017 | 46 | 0.610 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 156 | 0.580 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 179 | 0.580 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 219 | 0.550 |
Why?
|
| Light | 1 | 2015 | 27 | 0.540 |
Why?
|
| Mice, Inbred BALB C | 3 | 2018 | 152 | 0.500 |
Why?
|
| Animals | 9 | 2018 | 7480 | 0.500 |
Why?
|
| Tissue Distribution | 3 | 2018 | 55 | 0.450 |
Why?
|
| Humans | 17 | 2018 | 29541 | 0.420 |
Why?
|
| Polyethyleneimine | 1 | 2011 | 1 | 0.420 |
Why?
|
| Lipids | 2 | 2012 | 215 | 0.390 |
Why?
|
| Receptors, Bombesin | 1 | 2010 | 8 | 0.390 |
Why?
|
| 3T3 Cells | 2 | 2018 | 13 | 0.340 |
Why?
|
| Spheroids, Cellular | 2 | 2018 | 28 | 0.340 |
Why?
|
| Polyethylene Glycols | 2 | 2018 | 72 | 0.340 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 122 | 0.320 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 539 | 0.310 |
Why?
|
| Oligopeptides | 2 | 2018 | 55 | 0.290 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 64 | 0.270 |
Why?
|
| Apoptosis | 2 | 2018 | 357 | 0.260 |
Why?
|
| Postural Balance | 1 | 2016 | 110 | 0.250 |
Why?
|
| Pesticides | 1 | 2016 | 190 | 0.240 |
Why?
|
| Occupational Exposure | 1 | 2016 | 225 | 0.230 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 235 | 0.230 |
Why?
|
| Transients and Migrants | 1 | 2016 | 282 | 0.230 |
Why?
|
| Female | 5 | 2018 | 18476 | 0.210 |
Why?
|
| Hispanic Americans | 1 | 2016 | 948 | 0.180 |
Why?
|
| Drug Resistance, Multiple | 1 | 2018 | 7 | 0.180 |
Why?
|
| Nanomedicine | 1 | 2018 | 17 | 0.170 |
Why?
|
| Infrared Rays | 1 | 2018 | 18 | 0.170 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2018 | 24 | 0.170 |
Why?
|
| Doxorubicin | 1 | 2018 | 91 | 0.170 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 50 | 0.170 |
Why?
|
| Pyrazines | 1 | 2018 | 14 | 0.170 |
Why?
|
| Hydrocephalus | 1 | 2018 | 13 | 0.160 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2018 | 7 | 0.160 |
Why?
|
| Flavonoids | 1 | 2018 | 20 | 0.160 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 257 | 0.160 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2018 | 24 | 0.160 |
Why?
|
| Hybridomas | 1 | 2017 | 4 | 0.160 |
Why?
|
| Copper Radioisotopes | 1 | 2017 | 3 | 0.160 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2017 | 2 | 0.160 |
Why?
|
| Cell Survival | 1 | 2018 | 275 | 0.160 |
Why?
|
| Pyridines | 1 | 2018 | 85 | 0.160 |
Why?
|
| Chelating Agents | 1 | 2017 | 17 | 0.160 |
Why?
|
| Organometallic Compounds | 1 | 2017 | 18 | 0.160 |
Why?
|
| Biological Transport | 2 | 2015 | 62 | 0.160 |
Why?
|
| Ligands | 2 | 2015 | 82 | 0.160 |
Why?
|
| Indoles | 1 | 2017 | 64 | 0.160 |
Why?
|
| Base Sequence | 2 | 2015 | 252 | 0.160 |
Why?
|
| Hela Cells | 2 | 2018 | 78 | 0.140 |
Why?
|
| NIH 3T3 Cells | 1 | 2015 | 45 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 75 | 0.130 |
Why?
|
| Protein Binding | 1 | 2015 | 199 | 0.130 |
Why?
|
| Infant Food | 1 | 2014 | 3 | 0.130 |
Why?
|
| Silicon Dioxide | 1 | 2014 | 8 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2014 | 13 | 0.130 |
Why?
|
| Chromatography, Affinity | 1 | 2014 | 16 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1021 | 0.120 |
Why?
|
| Caveolins | 1 | 2011 | 2 | 0.100 |
Why?
|
| Cations | 1 | 2011 | 9 | 0.100 |
Why?
|
| Intracellular Space | 1 | 2010 | 16 | 0.100 |
Why?
|
| Luciferases, Firefly | 1 | 2010 | 3 | 0.100 |
Why?
|
| Cell Line | 1 | 2011 | 448 | 0.090 |
Why?
|
| Kinetics | 1 | 2010 | 207 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2016 | 914 | 0.060 |
Why?
|
| North Carolina | 1 | 2016 | 1439 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2018 | 10 | 0.040 |
Why?
|
| Maze Learning | 1 | 2018 | 17 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 81 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2018 | 172 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2018 | 372 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 650 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 808 | 0.030 |
Why?
|
| Male | 2 | 2018 | 18199 | 0.030 |
Why?
|
| Reagent Strips | 1 | 2014 | 4 | 0.030 |
Why?
|
| Powders | 1 | 2014 | 6 | 0.030 |
Why?
|
| DNA Probes | 1 | 2014 | 18 | 0.030 |
Why?
|
| Infant Formula | 1 | 2014 | 11 | 0.030 |
Why?
|
| Equipment Design | 1 | 2014 | 168 | 0.030 |
Why?
|
| Rats | 1 | 2018 | 1715 | 0.030 |
Why?
|
| Adult | 1 | 2016 | 8698 | 0.030 |
Why?
|
| Aged | 1 | 2016 | 9658 | 0.030 |
Why?
|
| Carbohydrates | 1 | 2012 | 6 | 0.030 |
Why?
|
| Nucleic Acids | 1 | 2012 | 6 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 110 | 0.030 |
Why?
|
| Middle Aged | 1 | 2016 | 11220 | 0.030 |
Why?
|
| Peptides | 1 | 2012 | 113 | 0.030 |
Why?
|
| Infant | 1 | 2014 | 972 | 0.020 |
Why?
|
| Receptors, sigma | 1 | 2010 | 3 | 0.020 |
Why?
|
| Amides | 1 | 2010 | 27 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 549 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2012 | 176 | 0.020 |
Why?
|